Search
    
    
                
                
                
              
              
              Seratrodast is used in the treatment of asthma. Seratrodast is an orally potent non-prostaglandin thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor blocker that inhibits allergic asthma caused by PGH2 analogues, leukotriene D4 (LTD4), and platelet-activating factor (PAF). Setrolaster can inhibit not only the immediate tracheal reaction, but also the delayed tracheal reaction and tracheal hyperreactivity.
| Items | Specifications | Results | 
| Appearance | Yellow to luminous powder | Yellow powder | 
| Loss on drying | ≤1.0% | 0.21% | 
| Residue on ignition | ≤1.0% | 0.01% | 
| Heavy metals | ≤20ppm | Conforms | 
| Residual solvents | Ethanol≤ 5000ppm | 810ppm | 
| Assay | ≥99.0% | 99.7% | 
| Product parameters | |
| Cas number: | 112665-43-7 | 
| Appearance: | Yellow to luminous powder | 
| Purity: | 99%min | 
| Package details: | 100g/bottle; 1kg/foil bag | 
| Brand: | Fortunachem | 

Used as an asthma agent.

      Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
        
      Quick Links
Add:
E-mail:
English                  
Español                  
français                  
العربية